• Tovetumab
    Tovetumab is an anti-PDGFRa monoclonal antibody designed for the treatment of cancer. It was developed by MedImmune, and trialed for use in glioblastoma...
    3 KB (150 words) - 16:58, 30 March 2024
  • Thumbnail for Insulin
    Insulin
    Ripretinib Sunitinib Sorafenib Toceranib Antibodies: Olaratumab Ramucirumab Tovetumab RET (GFL) SCF (c-Kit) Agonists: Ancestim Stem cell factor Kinase inhibitors:...
    121 KB (13,799 words) - 06:42, 1 July 2024
  • Thumbnail for Testosterone
    Testosterone
    Ripretinib Sunitinib Sorafenib Toceranib Antibodies: Olaratumab Ramucirumab Tovetumab RET (GFL) SCF (c-Kit) Agonists: Ancestim Stem cell factor Kinase inhibitors:...
    150 KB (15,741 words) - 10:52, 27 June 2024
  • Thumbnail for Dexamethasone
    Dexamethasone
    Ripretinib Sunitinib Sorafenib Toceranib Antibodies: Olaratumab Ramucirumab Tovetumab RET (GFL) SCF (c-Kit) Agonists: Ancestim Stem cell factor Kinase inhibitors:...
    68 KB (5,993 words) - 00:47, 13 July 2024
  • Thumbnail for Amitriptyline
    Amitriptyline
    Ripretinib Sunitinib Sorafenib Toceranib Antibodies: Olaratumab Ramucirumab Tovetumab RET (GFL) SCF (c-Kit) Agonists: Ancestim Stem cell factor Kinase inhibitors:...
    92 KB (8,667 words) - 19:29, 28 June 2024
  • Cerebrolysin
    Ripretinib Sunitinib Sorafenib Toceranib Antibodies: Olaratumab Ramucirumab Tovetumab RET (GFL) SCF (c-Kit) Agonists: Ancestim Stem cell factor Kinase inhibitors:...
    13 KB (1,177 words) - 18:50, 10 July 2024
  • Thumbnail for Erythropoietin
    Erythropoietin
    Ripretinib Sunitinib Sorafenib Toceranib Antibodies: Olaratumab Ramucirumab Tovetumab RET (GFL) SCF (c-Kit) Agonists: Ancestim Stem cell factor Kinase inhibitors:...
    31 KB (3,413 words) - 23:30, 21 June 2024
  • Thumbnail for Dehydroepiandrosterone
    Dehydroepiandrosterone
    Ripretinib Sunitinib Sorafenib Toceranib Antibodies: Olaratumab Ramucirumab Tovetumab RET (GFL) SCF (c-Kit) Agonists: Ancestim Stem cell factor Kinase inhibitors:...
    42 KB (3,935 words) - 04:01, 30 April 2024
  • Anti-VEGF
    Ripretinib Sunitinib Sorafenib Toceranib Antibodies: Olaratumab Ramucirumab Tovetumab RET (GFL) SCF (c-Kit) Agonists: Ancestim Stem cell factor Kinase inhibitors:...
    14 KB (1,671 words) - 12:47, 23 April 2024
  • Thumbnail for Trastuzumab deruxtecan
    Trastuzumab deruxtecan
    Ripretinib Sunitinib Sorafenib Toceranib Antibodies: Olaratumab Ramucirumab Tovetumab RET (GFL) SCF (c-Kit) Agonists: Ancestim Stem cell factor Kinase inhibitors:...
    25 KB (2,085 words) - 03:15, 6 July 2024
  • Thumbnail for Osimertinib
    Osimertinib
    Ripretinib Sunitinib Sorafenib Toceranib Antibodies: Olaratumab Ramucirumab Tovetumab RET (GFL) SCF (c-Kit) Agonists: Ancestim Stem cell factor Kinase inhibitors:...
    17 KB (1,489 words) - 05:47, 7 April 2024
  • Thumbnail for Nintedanib
    Nintedanib
    Ripretinib Sunitinib Sorafenib Toceranib Antibodies: Olaratumab Ramucirumab Tovetumab RET (GFL) SCF (c-Kit) Agonists: Ancestim Stem cell factor Kinase inhibitors:...
    34 KB (3,021 words) - 04:42, 11 July 2024
  • Thumbnail for Fruquintinib
    Fruquintinib
    Ripretinib Sunitinib Sorafenib Toceranib Antibodies: Olaratumab Ramucirumab Tovetumab RET (GFL) SCF (c-Kit) Agonists: Ancestim Stem cell factor Kinase inhibitors:...
    10 KB (579 words) - 06:46, 26 June 2024
  • Thumbnail for Cetuximab
    Cetuximab
    Ripretinib Sunitinib Sorafenib Toceranib Antibodies: Olaratumab Ramucirumab Tovetumab RET (GFL) SCF (c-Kit) Agonists: Ancestim Stem cell factor Kinase inhibitors:...
    26 KB (2,542 words) - 19:54, 20 March 2024
  • Thumbnail for Repotrectinib
    Repotrectinib
    Ripretinib Sunitinib Sorafenib Toceranib Antibodies: Olaratumab Ramucirumab Tovetumab RET (GFL) SCF (c-Kit) Agonists: Ancestim Stem cell factor Kinase inhibitors:...
    10 KB (661 words) - 04:10, 26 June 2024
  • IGF-1 LR3
    Ripretinib Sunitinib Sorafenib Toceranib Antibodies: Olaratumab Ramucirumab Tovetumab RET (GFL) SCF (c-Kit) Agonists: Ancestim Stem cell factor Kinase inhibitors:...
    5 KB (412 words) - 23:17, 19 June 2023
  • Bevacizumab
    Ripretinib Sunitinib Sorafenib Toceranib Antibodies: Olaratumab Ramucirumab Tovetumab RET (GFL) SCF (c-Kit) Agonists: Ancestim Stem cell factor Kinase inhibitors:...
    74 KB (6,565 words) - 05:35, 13 June 2024
  • Thumbnail for List of therapeutic monoclonal antibodies
    List of therapeutic monoclonal antibodies
    Staphylococcus aureus Tositumomab Bexxar mouse CD20 Y follicular lymphoma Tovetumab mab human PDGFRA cancer Tralokinumab Adtralza, Adbry mab human IL-13 Y...
    135 KB (4,054 words) - 22:35, 2 July 2024
  • Thumbnail for Insulin-like growth factor 1
    Insulin-like growth factor 1
    Ripretinib Sunitinib Sorafenib Toceranib Antibodies: Olaratumab Ramucirumab Tovetumab RET (GFL) SCF (c-Kit) Agonists: Ancestim Stem cell factor Kinase inhibitors:...
    36 KB (4,822 words) - 06:03, 26 June 2024
  • Amivantamab
    Ripretinib Sunitinib Sorafenib Toceranib Antibodies: Olaratumab Ramucirumab Tovetumab RET (GFL) SCF (c-Kit) Agonists: Ancestim Stem cell factor Kinase inhibitors:...
    23 KB (1,755 words) - 04:41, 3 July 2024
  • Thumbnail for Faricimab
    Faricimab
    Ripretinib Sunitinib Sorafenib Toceranib Antibodies: Olaratumab Ramucirumab Tovetumab RET (GFL) SCF (c-Kit) Agonists: Ancestim Stem cell factor Kinase inhibitors:...
    20 KB (1,543 words) - 06:38, 10 March 2024
  • Thumbnail for Dihexa
    Dihexa
    Ripretinib Sunitinib Sorafenib Toceranib Antibodies: Olaratumab Ramucirumab Tovetumab RET (GFL) SCF (c-Kit) Agonists: Ancestim Stem cell factor Kinase inhibitors:...
    6 KB (460 words) - 19:16, 8 July 2024
  • Thumbnail for Filgrastim
    Filgrastim
    Ripretinib Sunitinib Sorafenib Toceranib Antibodies: Olaratumab Ramucirumab Tovetumab RET (GFL) SCF (c-Kit) Agonists: Ancestim Stem cell factor Kinase inhibitors:...
    24 KB (1,700 words) - 04:21, 2 July 2024
  • Thumbnail for HER2
    HER2
    Ripretinib Sunitinib Sorafenib Toceranib Antibodies: Olaratumab Ramucirumab Tovetumab RET (GFL) SCF (c-Kit) Agonists: Ancestim Stem cell factor Kinase inhibitors:...
    43 KB (4,740 words) - 14:23, 7 July 2024
  • Vascular endothelial growth factor
    Ripretinib Sunitinib Sorafenib Toceranib Antibodies: Olaratumab Ramucirumab Tovetumab RET (GFL) SCF (c-Kit) Agonists: Ancestim Stem cell factor Kinase inhibitors:...
    40 KB (4,580 words) - 05:24, 3 June 2024
  • Thumbnail for Testosterone (medication)
    Testosterone (medication)
    Ripretinib Sunitinib Sorafenib Toceranib Antibodies: Olaratumab Ramucirumab Tovetumab RET (GFL) SCF (c-Kit) Agonists: Ancestim Stem cell factor Kinase inhibitors:...
    110 KB (10,711 words) - 05:46, 12 July 2024
  • Thumbnail for Epidermal growth factor receptor
    Epidermal growth factor receptor
    Ripretinib Sunitinib Sorafenib Toceranib Antibodies: Olaratumab Ramucirumab Tovetumab RET (GFL) SCF (c-Kit) Agonists: Ancestim Stem cell factor Kinase inhibitors:...
    60 KB (6,879 words) - 09:57, 15 January 2024
  • Thumbnail for Tyrosine kinase inhibitor
    Tyrosine kinase inhibitor
    Ripretinib Sunitinib Sorafenib Toceranib Antibodies: Olaratumab Ramucirumab Tovetumab RET (GFL) SCF (c-Kit) Agonists: Ancestim Stem cell factor Kinase inhibitors:...
    9 KB (1,081 words) - 04:46, 16 June 2022
  • Thumbnail for Neurotrophin
    Neurotrophin
    Ripretinib Sunitinib Sorafenib Toceranib Antibodies: Olaratumab Ramucirumab Tovetumab RET (GFL) SCF (c-Kit) Agonists: Ancestim Stem cell factor Kinase inhibitors:...
    27 KB (3,071 words) - 04:54, 3 June 2024
  • Thumbnail for Alectinib
    Alectinib
    Ripretinib Sunitinib Sorafenib Toceranib Antibodies: Olaratumab Ramucirumab Tovetumab RET (GFL) SCF (c-Kit) Agonists: Ancestim Stem cell factor Kinase inhibitors:...
    22 KB (1,787 words) - 05:10, 1 July 2024